KENDALL GODT: Open Payments
NPI 1487338406 · CENTEREACH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 30 payments from 9 companies in 2025. Trend: 2023 $128 · 2024 $735 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $208 |
| ACADIA Pharmaceuticals Inc | 2 | $141 |
| Lundbeck LLC | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: VRAYLAR, REXULTI, NUPLAZID, Auvelity, COBENFY, HETLIOZ, UZEDY, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
